Metabolism of 2-nitrofluorene, 2-aminofluorene and 2-acylaminofluorenes in rat and dog and the role of intestinal bacteria

References

• BIELSCHOWSKY, F., 1945, A metabolite of 2 -acetamidofluorene. Biochemical Journal, 39, 287–289.
   PubMedGoogle Scholar
• CAMPBELL, R. M. and MILTON, L. L., 1984, Capillary column gas chromatographic determination of nitro polycyclic aromatic compounds in particulate extracts. Analytical Chemistry, 56, 1026–1030.
   Web of Science ®Google Scholar
• DULL, B. J., SALATA, K. and GOLDMAN, P., 1987, Role of the intestinal flora in the acetylation of sulphasalazine metabolites. Biochemical Pharmacology, 36, 3772–3774.
   PubMed Web of Science ®Google Scholar
• Fu, P. P., 1990, Metabolism of nitro-polycyclic aromatic hydrocarbons. Drug Metabolism Reviews, 22, 209–268.
   PubMed Web of Science ®Google Scholar
• GARDNER, D. M. and RENWICK, A. G., 1978, The reduction of nitrobenzoic acids in the rat. Xenobiotica, 8, 679–690.
   PubMed Web of Science ®Google Scholar
• GINGELL, R., BRIDGES, J. W. and WILLIAMS, R. T., 1971, The role of the gut flora in the metabolism of prontosil and neoprontosil in the rat. Xenobiotica, 1, 143–156.
   PubMedGoogle Scholar
• GOLDIN, B. R., 1990, Intestinal microflora: Metabolism of drugs and carcinogens. Annals of Medicine, 22, 43–48.
   PubMed Web of Science ®Google Scholar
• HAYAKAWA, K., MURAHASHI, T., BUTOH M., MIYAZAKI, M., 1995, Determination of 1,3-, 1,6-, and 1,8-dinitropyrenes and 1-nitropyrene in urban air by high-performance liquid chromatography using chemiluminescence detection. Environmental Science and Technology, 29, 928–932.
   Google Scholar
• HOWARD, P. C., BELAND, F. A. and CERNIGLIA, C. E., 1983, Reduction of the carcinogen 1-nitropyrene to 1-aminopyrene by rat intestinal bacteria. Carcinogenesis, 4, 985–990.
   PubMed Web of Science ®Google Scholar
• IsmDA, M., KITAMURA, S. and TATSUMI, K., 1996, Purification of an cikketoalkene double bond reductase from Salmonella typhimurium. Biochemistry and Molecular Biology International, 39, 1157–1165.
   PubMedGoogle Scholar
• KINOUCHI, T., KATAOKA, K., MIYANISHI, K., AKIMOTO, S. and OHNISHI, Y., 1993, Biological activities of the intestinal microflora in mice treated with antibiotics or untreated and the effects of the microflora on absorption and metabolic activation of orally administered glutathione conjugates of K-region epoxides of 1-nitropyrene. Carcinogenesis, 14, 869–874.
   PubMed Web of Science ®Google Scholar
• KINOUCHI, T., MANABE, Y., WAKISAKA, K. and OHNISHI, Y., 1982, Biotransformation of 1-nitropyrene in intestinal anaerobic bacteria. Microbiology and Immunology, 26, 993–1005.
   PubMed Web of Science ®Google Scholar
• KITAMURA, S., KUWASAKO, M., OHTA, S. and TATSUMI, K., 1999a, Reductive debromination of ci-(bromoisovaleryDurea by intestinal bacteria. Journal of Pharmacy and Pharmacology, 51, 79–84.
   PubMed Web of Science ®Google Scholar
• KITAMURA, S., MITA, M., MATSUDA, K., OHTA, S. and TATSUMI, K., 2000, Reduction of stilbene oxide and styrene oxide to the corresponding alkenes by intestinal bacteria. Xenobiotica, 30, 359–369.
   PubMed Web of Science ®Google Scholar
• KITAMURA, S., MITA, M., SHIMIZU, Y., SUGIHARA, K. and OHTA, S., 1999b, Conversion of dieldrin to aldrin by intestinal bacteria in rats. Biological and Pharmaceutical Bulletin, 22, 880–882.
   PubMedGoogle Scholar
• KITAMURA, S., NARAI, N., HAYASHI, M. and TATSUMI, K., 1983, Rabbit liver enzymes responsible for reduction of nitropolycyclic aromatic hydrocarbons. Chemical and Pharmaceutical Bulletin, 31, 776–779.
   PubMedGoogle Scholar
• KITAMURA, S., SUGIHARA, K., KUWASAKO, M. and TATSUMI, K., 1997, The role of mammalian intestinal bacteria in the reductive metabolism of zonisamide. Journal of Pharmacy and Pharmacology, 49, 253–256.
   PubMed Web of Science ®Google Scholar
• KITAMURA, S. and TATSUMI, K., 1996, Metabolism in vivo of 1-nitropyrene, an environmental pollutant, in fish. Biological and Pharmaceutical Bulletin, 19, 1524–1526.
   PubMedGoogle Scholar
• KITAMURA, S. and TATSUMI, K., 1997, 1-Nitropyrene-metabolizing activities of fish liver preparations. Bulletin of Environmental Contamination and Toxicology, 58, 448–455.
   PubMedGoogle Scholar
• LEVIN, A. A. and DENT, J. G., 1982, Comparison of the metabolism of nitrobenzene by hepatic microsomes and cecal microflora from Fischer-344 rats in vitro and the relative importance of each in vivo. Drug Metabolism and Disposition, 10,450–454.
   PubMed Web of Science ®Google Scholar
• MILLER, E. C., FLETCHER, T. L., MARGRETH, A. and MILLER, J. A., 1962, The carcinogenicity of derivatives of fluorene and biphenyl: fluoro derivatives as probe for active sites in 2-acetylaminofluorene. Cancer Research, 22, 1002–1014.
   Web of Science ®Google Scholar
• MILLER, J. A., SANDIN, R. B., MILLER, E. C. and RuscH, H. P., 1955, The carcinogenicity of compounds related to 2-acetylaminofluorene. II. Variations in the bridges and the 2-substituent. Cancer Research, 15, 188–199.
   PubMed Web of Science ®Google Scholar
• MoLLER, L., CORRIE, M., MIDTVEDT, T., RAFTER, J. and GUSTAFSSON, J.-A., 1988, The role of the intestinal micro flora in the formation of mutagenic metabolites from the carcinogenic air pollutant 2-nitrofluorene. Carcinogenesis, 9, 823–830.
   Google Scholar
• MoLLER, L., RAFTER, J. and GUSTAFSSON, J.-A., 1987, Metabolism of the carcinogenic air pollutant 2-nitrofluorene in the rat. Carcinogenesis, 8, 637–645.
   Google Scholar
• MoLLER, L., TORNDAL, U.-B., ERIKSSON, L. C. and GUSTAFSSON, J.-À., 1989, The air pollutant 2-nitrofluorene as initiator and promoter in a liver model for chemical carcinogenesis. Carcinogenesis, 10, 435–440.
   Google Scholar
• MoLLER, L., ZEISIG, M., MIDTVED T. and GUSTAFSSON, J.-A., 1994, Intestinal microflora enhances formation of DNA adducts following administration of 2 -NF and 2-AAF. Carcinogenesis, 15, 857–861.
   Google Scholar
• NARAI, N., KITAMURA, S. and TATSUMI, K., 1984, A comparative study on 1-nitropyrene and nitrofurazone reductases in Escherichia coli. Journal of Pharmacobio-Dynamics, 7, 407–413.
   PubMedGoogle Scholar
• OKUMURA, F., UEDA, 0., KITAMURA, S. and TATSUMI, K., 1995, N-acetylation and N-formylation of carcinogenic arylamines and related compounds in dogs. Carcinogenesis, 16, 71–76.
   Google Scholar
• PEPPERCORN, M. A. and GOLDMAN, P., 1972, The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. Journal of Pharmacology and Experimental Therapeutics, 181, 555–562.
   PubMed Web of Science ®Google Scholar
• RENWICK, A. G., EVANS, S. P., SWEATMAN, T. W., CUMBERLAND, J. and GEORGE, C. F., 1982, The role of the gut flora in the reduction of sulphinpyrazone in the rat. Biochemical Pharmacology, 31, 2649–2656.
   PubMed Web of Science ®Google Scholar
• ROSENKRANZ, H. S. and MERMELSTEIN, R., 1983, Mutagenicity and genotoxicity of nitroarenes, All nitro-containing chemicals were not created equal. Mutation Research, 114, 217–267.
   PubMed Web of Science ®Google Scholar
• SAITO, K., KAMATAKI, T. and KATO, R., 1984, Participation of cytochrome P-450 in reductive metabolism of 1-nitropyrene by rat liver microsomes. Cancer Research, 44, 3169–3173.
   PubMed Web of Science ®Google Scholar
• SCHELINE, R. R., 1973, Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacological Reviews, 25, 451–523.
   PubMed Web of Science ®Google Scholar
• SUGIHARA, K., KITAMURA, S. and TATSUMI, K., 1996, Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide. Drug Metabolism and Disposition, 24, 199–202.
   PubMed Web of Science ®Google Scholar
• TATSUMI, K. and AMANO, H., 1987, Biotransformation of 1-nitropyrene and 2-nitrofluorene to novel metabolites, the corresponding formylamino compounds, in animal bodies. Biochemical and Biophysical Research Communications, 142, 376–382.
   PubMed Web of Science ®Google Scholar
• TATSUMI, K., KITAMURA, S. and NARAI, N., 1986, Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations. Cancer Research, 46, 1089–1093.
   PubMed Web of Science ®Google Scholar
• TATSUMI, K., KIT AMURA, S., AMANO, H. and UEDA, K., 1989, Comparative study on metabolic formation of N-arylformamides and N-arylacetamides from carcinogenic arylamines in mammalian species. Cancer Research, 49, 2059–2064.
   PubMedGoogle Scholar
• TöRNQUIST, S., WILLER, L., GABRIELSSON, J., GUSTAFSSON, J.-A. and TOFTGARD, R., 1990, 2-Nitrofluorene metabolism in the rat lung. Pharmacokinetic and metabolic effects of b-naphthoflavone treatment. Carcinogenesis, 11, 1249–1254.
   Google Scholar
• UEDA, 0., KITAMURA, S. and TATSUMI, K., 1996, Further metabolism of 2-formylaminofluorene, a metabolite of 2-aminofluorene, in rats. Biological and Pharmaceutical Bulletin, 19, 330–333.
   Google Scholar
• WANG, C. Y., LEE, M. S., KING, C. M., WARNER, P. 0., 1980, Evidence for nitroaromatics as direct-acting mutagens of airborne particulates. Chemosphere, 9, 83–87.
   Google Scholar
• WEISBURGER, J. H., GRANTHAM, P. H., Ho RTON, R. E. and WEISBURGER, E. K., 1970, Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide in germ-free rats. Biochemical Pharmacology, 19, 151–162.
   PubMed Web of Science ®Google Scholar
• WEISBURGER, E. K. and WEISBURGER, J. H., 1954, ortho-Hydroxy derivatives of the carcinogen 2-acetylaminofluorene. Journal of Organic Chemistry, 19, 964–972.
   Google Scholar
• WEISBURGER, E. K. and WEISBURGER, J. H., 1955,2 -Acetylamino-5 -hydroxyfluorene, a metabolite of the carcinogen 2-acetylaminofluorene. Journal of Organic Chemistry, 20, 1396–1401.
   Google Scholar
• ZACHARIAH, P. K. and JucHAu, M. R., 1974, The role of gut flora in the reduction of aromatic nitro-groups. Drug Metabolism and Disposition, 2, 74–78.
   PubMed Web of Science ®Google Scholar